X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-27 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | GC, Corp Sec | S - Sale+OE | $3.01 | -9,406 | 173,999 | -5% | -$28,311 | |||||
2026-02-02 | ABSI | Absci Corp | McClain Sean | CEO | S - Sale | $2.99 | -26,761 | 8,334,567 | 0% | -$80,015 | ||||||
2026-02-02 | ABSI | Absci Corp | Jonasson Zachariah | CFO , CBO | S - Sale | $2.99 | -17,496 | 383,538 | -4% | -$52,313 | ||||||
| D | 2026-03-03 | AIRJ | Airjoule Technologies Corp. | Gutke Jeff | Chief Administrative Officer | S - Sale+OE | $3.17 | -3,462 | 186,018 | -2% | -$10,975 | |||||
2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Rucci Carolyn M. | SVP, GC | S - Sale | $1.39 | -69,772 | 588,378 | -11% | -$96,983 | ||||||
2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Malabre Richard C | SVP, Chief Accounting Officer | S - Sale | $1.39 | -49,524 | 299,390 | -14% | -$68,838 | ||||||
2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Grund Nicholas | Chief Commercial Officer | S - Sale | $1.39 | -84,829 | 561,750 | -13% | -$117,912 | ||||||
2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres | S - Sale | $1.39 | -341,305 | 3,457,722 | -9% | -$474,414 | ||||||
2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Ostrowski Erik | SVP, CFO, CBO, Treasurer | S - Sale | $1.39 | -34,951 | 672,635 | -5% | -$48,582 | ||||||
2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | S - Sale | $1.39 | -67,658 | 948,432 | -7% | -$94,045 | ||||||
2026-03-02 | ALEC | Alector, Inc. | Wong-Sarad Grace | Principal Accounting Officer | S - Sale | $2.12 | -8,071 | 110,832 | -7% | -$17,138 | ||||||
2026-02-26 | ALEC | Alector, Inc. | Wong-Sarad Grace | Principal Accounting Officer | S - Sale | $2.50 | -4,079 | 118,903 | -3% | -$10,198 | ||||||
2026-03-02 | ALEC | Alector, Inc. | Rosenthal Arnon | CEO | S - Sale | $2.12 | -81,864 | 6,268,551 | -1% | -$173,822 | ||||||
2026-03-02 | ALEC | Alector, Inc. | Berkley Neil Lindsay | CFO, Chief Business Officer | S - Sale | $2.12 | -29,649 | 344,660 | -8% | -$62,954 | ||||||
| D | 2026-02-02 | ALLO | Allogene Therapeutics, Inc. | Roberts Zachary | EVP of R, D | S - Sale+OE | $1.77 | -35,700 | 581,166 | -6% | -$63,189 | |||||
| D | 2026-02-02 | ALLO | Allogene Therapeutics, Inc. | Douglas Earl Martin | SVP, GC | S - Sale+OE | $1.76 | -22,900 | 564,948 | -4% | -$40,304 | |||||
| D | 2026-02-02 | ALLO | Allogene Therapeutics, Inc. | Parker Geoffrey M. | CFO | S - Sale+OE | $1.76 | -24,001 | 1,252,795 | -2% | -$42,242 | |||||
| D | 2026-02-02 | ALLO | Allogene Therapeutics, Inc. | Beneski Benjamin Machinas | SVP, Chief Technical Officer | S - Sale+OE | $1.73 | -7,549 | 210,172 | -3% | -$13,060 | |||||
| D | 2026-02-02 | ALLO | Allogene Therapeutics, Inc. | Chang David D | Pres, CEO | S - Sale+OE | $1.80 | -95,269 | 8,099,058 | -1% | -$171,484 | |||||
2026-03-02 | ALLO | Allogene Therapeutics, Inc. | Beneski Benjamin Machinas | SVP, Chief Technical Officer | S - Sale | $2.60 | -7,132 | 203,040 | -3% | -$18,543 | ||||||
| M | 2026-02-27 | ANNA | Aleanna, Inc. | Wilder C John | 10% | S - Sale | $3.65 | -146,773 | 30,331,951 | 0% | -$535,092 | |||||
2026-03-02 | ATOM | Atomera Inc | Bibaud Scott A. | CEO, Pres | S - Sale | $4.95 | -10,075 | 709,741 | -1% | -$49,871 | ||||||
2026-03-02 | ATOM | Atomera Inc | Mears Robert J | CTO | S - Sale | $4.95 | -3,979 | 286,069 | -1% | -$19,696 | ||||||
2026-03-02 | ATOM | Atomera Inc | Laurencio Francis | CFO | S - Sale | $4.95 | -4,799 | 259,963 | -2% | -$23,755 | ||||||
2026-03-03 | BFLY | Butterfly Network, Inc. | Carlson Megan | CAO, SVP, Finance | S - Sale | $3.71 | -41,978 | 617,631 | -6% | -$155,822 | ||||||
2026-03-03 | BFLY | Butterfly Network, Inc. | Cashman Steve | Chief Business Officer | S - Sale | $3.71 | -42,540 | 2,377,386 | -2% | -$157,908 | ||||||
2026-02-26 | BFLY | Butterfly Network, Inc. | Cashman Steve | Chief Business Officer | S - Sale | $4.35 | -250,000 | 1,931,884 | -11% | -$1,087,000 | ||||||
2026-03-03 | BFLY | Butterfly Network, Inc. | Caezza Nicholas | Deputy GC | S - Sale | $3.71 | -14,209 | 312,040 | -4% | -$52,744 | ||||||
2026-03-03 | BFLY | Butterfly Network, Inc. | Devivo Joseph | Pres, CEO | S - Sale | $3.71 | -161,275 | 8,513,048 | -2% | -$598,653 | ||||||
2026-03-03 | BIRD | Allbirds, Inc. | Vernachio Joseph | CEO | S - Sale | $2.69 | -4,413 | 85,569 | -5% | -$11,872 | ||||||
2026-02-18 | BRLT | Brilliant Earth Group, Inc. | Dziesietnik Sharon | Chief Operations Officer | S - Sale | $1.37 | -19,687 | 446,736 | -4% | -$26,971 | ||||||
| DM | 2026-02-17 | CDLX | Cardlytics, Inc. | Gupta Amit | CEO | S - Sale+OE | $0.91 | -97,208 | 659,644 | -13% | -$88,765 | |||||
2026-02-03 | CLNN | Clene Inc. | Ugwumba Chidozie | 10% | S - Sale | $4.10 | -5,559 | 550,000 | -1% | -$22,792 | ||||||
2026-03-04 | CLOV | Clover Health Investments, Corp. /De | Priest Brady Patrick | CEO of Home Care | S - Sale | $2.17 | -175,000 | 1,998,584 | -8% | -$379,750 | ||||||
| D | 2026-02-24 | CRBU | Caribou Biosciences, Inc. | Khan Ruhi Ahmad | Chief Business Officer | S - Sale+OE | $1.96 | -6,938 | 104,998 | -6% | -$13,598 | |||||
| D | 2026-02-24 | CRBU | Caribou Biosciences, Inc. | McClung Barbara G | GC | S - Sale+OE | $1.96 | -6,938 | 481,564 | -1% | -$13,598 | |||||
2026-02-25 | CRBU | Caribou Biosciences, Inc. | Kelly Timothy P | CTO | S - Sale | $1.93 | -6,228 | 73,125 | -8% | -$12,020 | ||||||
| M | 2026-02-19 | CRCT | Cricut, Inc. | Ashish Arora | CEO, 10% | S - Sale | $4.56 | -180,000 | 3,798,453 | -5% | -$821,664 | |||||
| M | 2026-03-02 | CRCT | Cricut, Inc. | Ashish Arora | CEO, 10% | S - Sale | $4.27 | -73,458 | 3,724,995 | -2% | -$313,853 | |||||
2026-03-04 | CRSF | Crisp Momentum Inc. | Jakota Games & Reels | 10% | S - Sale | $0.10 | -150,000,000 | 94,295,648 | -61% | -$15,000,000 | ||||||
| M | 2026-02-03 | CSAI | Cloudastructure, Inc. | Bentley Sheldon Richard | Founder, 10% | S - Sale | $0.58 | -50,000 | 50,000 | -50% | -$29,000 | |||||
| M | 2026-02-10 | CSAI | Cloudastructure, Inc. | Bentley Sheldon Richard | Founder, 10% | S - Sale | $0.61 | -50,000 | 0 | -100% | -$30,500 | |||||
| D | 2026-03-02 | DGXX | Digi Power X Inc. | Amar Alec | Pres | S - Sale+OE | $2.86 | -27,500 | 1,413,949 | -2% | -$78,650 | |||||
2026-02-17 | DTI | Drilling Tools International Corp | Domino Michael Wayne Jr. | Pres, DTR Division | S - Sale | $3.96 | -6,249 | 1,426,805 | 0% | -$24,746 | ||||||
| D | 2026-02-18 | DTIL | Precision Biosciences Inc | Amoroso Michael | Pres, CEO | S - Sale+OE | $3.84 | -20,559 | 243,392 | -8% | -$78,947 | |||||
| D | 2026-02-18 | DTIL | Precision Biosciences Inc | Kelly John Alexander | CFO | S - Sale+OE | $3.84 | -8,149 | 125,883 | -6% | -$31,292 | |||||
| D | 2026-02-18 | DTIL | Precision Biosciences Inc | Scimeca Dario | GC, Secretary | S - Sale+OE | $3.84 | -4,925 | 56,457 | -8% | -$18,912 | |||||
| D | 2026-02-18 | DTIL | Precision Biosciences Inc | Smith J. Jefferson | Chief Research Officer | S - Sale+OE | $3.84 | -4,925 | 129,857 | -4% | -$18,912 | |||||
2026-03-03 | EDIT | Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO | S - Sale | $2.02 | -5,394 | 263,693 | -2% | -$10,894 | ||||||
2026-02-04 | EGHT | 8X8 Inc /De/ | Middleton Hunter | Chief Product Officer | S - Sale | $2.50 | -85,044 | 652,943 | -12% | -$212,814 | ||||||
2026-02-17 | EGHT | 8X8 Inc /De/ | Denny Laurence | GC | S - Sale | $2.55 | -5,000 | 376,771 | -1% | -$12,732 | ||||||
| D | 2026-02-19 | EQ | Equillium, Inc. | Zedelmayer Christine | SVP, COO | S - Sale+OE | $1.76 | -185,937 | 191,444 | -49% | -$328,104 | |||||
| M | 2026-02-06 | EU | Encore Energy Corp. | Sheriff William M | See Remarks | S - Sale | $2.76 | -24,000 | 2,216,931 | -1% | -$66,240 | |||||
2026-02-02 | EXFY | Expensify, Inc. | Barrett David Michael | CEO | S - Sale | $1.45 | -30,000 | 1,531,047 | -2% | -$43,500 | ||||||
2026-03-02 | EXFY | Expensify, Inc. | Barrett David Michael | CEO | S - Sale | $0.90 | -30,000 | 1,501,047 | -2% | -$27,000 | ||||||
| DM | 2026-02-24 | FLD | Fold Holdings, Inc. | Repass Wolfe | CFO | S - Sale+OE | $1.48 | -19,041 | 210,621 | -8% | -$28,237 | |||||
| DM | 2026-02-20 | FLD | Fold Holdings, Inc. | Repass Wolfe | CFO | S - Sale+OE | $1.53 | -16,585 | 198,877 | -8% | -$25,406 | |||||
| D | 2026-02-19 | FLD | Fold Holdings, Inc. | Repass Wolfe | CFO | S - Sale+OE | $1.48 | -21,857 | 176,329 | -11% | -$32,436 | |||||
| DM | 2026-02-26 | FLD | Fold Holdings, Inc. | Repass Wolfe | CFO | S - Sale+OE | $1.47 | -22,852 | 253,535 | -8% | -$33,579 | |||||
2026-03-02 | FLD | Fold Holdings, Inc. | Repass Wolfe | CFO | S - Sale | $1.42 | -11,281 | 242,254 | -4% | -$16,053 | ||||||
| D | 2026-02-18 | GERN | Geron Corp | Robertson Michelle | EVP, CFO | S - Sale+OE | $1.94 | -9,855 | 17,645 | -36% | -$19,119 | |||||
2026-02-26 | GIFT | Giftify, Inc. | Interactive Communications International, Inc. | Former 10% Owner | S - Sale | $0.93 | -17,610 | 2,577,760 | -1% | -$16,448 | ||||||
2026-03-02 | GNLX | Genelux Corp | Thomas John | Dir | S - Sale | $2.90 | -10,000 | 482,784 | -2% | -$28,957 | ||||||
2026-02-20 | GPRO | Gopro, Inc. | McGee Brian | EVP, CFO, COO | S - Sale | $0.79 | -59,509 | 688,922 | -8% | -$47,137 | ||||||
2026-03-03 | HNST | Honest Company, Inc. | Winchell Stephen | Chief Innovation Officer | S - Sale | $2.84 | -73,685 | 517,466 | -12% | -$209,265 | ||||||
| D | 2026-03-02 | INDI | Indie Semiconductor, Inc. | Wu Naixi | CFO | S - Sale+OE | $3.56 | -17,162 | 77,059 | -18% | -$61,153 | |||||
| D | 2026-03-02 | INDI | Indie Semiconductor, Inc. | Aoki Ichiro | Pres | S - Sale+OE | $3.56 | -4,573 | 4,540,314 | 0% | -$16,288 | |||||
| D | 2026-03-02 | INDI | Indie Semiconductor, Inc. | McClymont Donald | CEO | S - Sale+OE | $3.56 | -90,644 | 5,316,933 | -2% | -$322,847 | |||||
| D | 2026-03-02 | INDI | Indie Semiconductor, Inc. | Wittmann Michael | COO | S - Sale+OE | $3.50 | -37,500 | 123,885 | -23% | -$131,423 | |||||
| M | 2026-02-23 | IRWD | Ironwood Pharmaceuticals Inc | Gaskins Tammi L | Chief Commercial Officer | S - Sale | $3.73 | -21,526 | 213,738 | -9% | -$80,328 | |||||
| M | 2026-02-23 | IRWD | Ironwood Pharmaceuticals Inc | McCourt Thomas A | CEO | S - Sale | $3.73 | -198,283 | 1,489,002 | -12% | -$739,929 | |||||
| M | 2026-02-23 | IRWD | Ironwood Pharmaceuticals Inc | Martini Gregory S. | CFO | S - Sale | $3.73 | -21,944 | 160,601 | -12% | -$81,888 | |||||
| M | 2026-02-23 | IRWD | Ironwood Pharmaceuticals Inc | John Minardo | GC | S - Sale | $3.73 | -36,492 | 363,886 | -9% | -$136,177 | |||||
| M | 2026-02-23 | IRWD | Ironwood Pharmaceuticals Inc | Silver Ronald | Principal Accounting Officer | S - Sale | $3.73 | -24,173 | 252,636 | -9% | -$90,206 | |||||
| M | 2026-02-23 | IRWD | Ironwood Pharmaceuticals Inc | Shetzline Michael | SVP, CMO, Head-Res, Drug | S - Sale | $3.73 | -32,582 | 1,059,862 | -3% | -$121,586 | |||||
| M | 2026-02-12 | ISPR | Ispire Technology Inc. | Pryzbyla Steven P. | CLO, Secretary | S - Sale | $3.29 | -9,000 | 390,664 | -2% | -$29,592 | |||||
| DM | 2026-02-17 | IVVD | Invivyd, Inc. | Lee Timothy Edward | Chief Commercial Officer | S - Sale+OE | $1.56 | -40,627 | 117,717 | -26% | -$63,350 | |||||
| DM | 2026-02-17 | IVVD | Invivyd, Inc. | Andersen Jill | GC, Secretary | S - Sale+OE | $1.56 | -67,710 | 182,236 | -27% | -$105,581 | |||||
| DM | 2026-02-17 | IVVD | Invivyd, Inc. | Duke William E. | CFO | S - Sale+OE | $1.56 | -40,627 | 107,717 | -27% | -$63,350 | |||||
| DM | 2026-02-17 | IVVD | Invivyd, Inc. | Green Julie | CHRO | S - Sale+OE | $1.56 | -40,627 | 107,717 | -27% | -$63,350 | |||||
| DM | 2026-02-17 | IVVD | Invivyd, Inc. | Allen Robert D. III | Chief Scientific Officer | S - Sale+OE | $1.56 | -37,581 | 114,487 | -25% | -$58,600 | |||||
| M | 2026-02-23 | JCTC | Jewett Cameron Trading Co Ltd | Oregon Community Foundation | 10% | S - Sale | $1.80 | -7,414 | 778,545 | -1% | -$13,364 | |||||
| M | 2026-02-19 | JCTC | Jewett Cameron Trading Co Ltd | Oregon Community Foundation | 10% | S - Sale | $1.81 | -46,250 | 785,959 | -6% | -$83,767 | |||||
| M | 2026-02-25 | JCTC | Jewett Cameron Trading Co Ltd | Oregon Community Foundation | 10% | S - Sale | $1.79 | -15,011 | 763,534 | -2% | -$26,803 | |||||
| M | 2026-02-03 | KOS | Kosmos Energy Ltd. | Inglis Andrew G | COB, CEO | S - Sale | $1.39 | -148,182 | 4,227,017 | -3% | -$205,241 | |||||
| M | 2026-02-03 | KOS | Kosmos Energy Ltd. | Marion Josh R. | SVP, GC | S - Sale | $1.38 | -22,940 | 194,125 | -11% | -$31,592 | |||||
| M | 2026-02-03 | KOS | Kosmos Energy Ltd. | Shah Nealesh D. | SVP, CFO | S - Sale | $1.39 | -79,124 | 1,705,167 | -4% | -$109,634 | |||||
| M | 2026-02-03 | KOS | Kosmos Energy Ltd. | Glass Ronald W. | VP, Chief Accounting Officer | S - Sale | $1.38 | -22,598 | 339,632 | -6% | -$31,125 | |||||
2026-02-17 | LAW | Cs Disco, Inc. | Crum Richard Francis | EVP, Chief Prod, Tech Officer | S - Sale | $3.07 | -6,508 | 355,363 | -2% | -$19,980 | ||||||
2026-03-02 | LAW | Cs Disco, Inc. | Garcia Susan | GC, Chief Compliance Officer | S - Sale | $3.24 | -5,956 | 152,921 | -4% | -$19,297 | ||||||
2026-02-17 | LAW | Cs Disco, Inc. | Herckis Karen | EVP, CHRO | S - Sale | $3.07 | -8,171 | 201,851 | -4% | -$25,085 | ||||||
2026-02-17 | LAW | Cs Disco, Inc. | Garcia Susan | GC, Chief Compliance Officer | S - Sale | $3.07 | -3,743 | 158,877 | -2% | -$11,491 | ||||||
2026-02-17 | LAW | Cs Disco, Inc. | Antoon Melanie | EVP, Chief Customer Officer | S - Sale | $3.07 | -9,289 | 289,493 | -3% | -$28,517 | ||||||
2026-03-02 | LAW | Cs Disco, Inc. | Antoon Melanie | EVP, Chief Customer Officer | S - Sale | $3.24 | -4,882 | 284,611 | -2% | -$15,818 | ||||||
2026-03-02 | LAW | Cs Disco, Inc. | Herckis Karen | EVP, CHRO | S - Sale | $3.24 | -3,978 | 197,873 | -2% | -$12,889 | ||||||
2026-03-02 | LAW | Cs Disco, Inc. | Crum Richard Francis | EVP, Chief Prod, Tech Officer | S - Sale | $3.24 | -6,262 | 349,101 | -2% | -$20,289 | ||||||
2026-03-02 | LUNG | Pulmonx Corp | Radhakrishnan Srikanth | Chief Science,Techn. Officer | S - Sale | $1.43 | -10,483 | 345,736 | -3% | -$14,991 | ||||||
2026-03-02 | LUNG | Pulmonx Corp | Lehman David Aaron | GC | S - Sale | $1.43 | -12,237 | 390,755 | -3% | -$17,499 | ||||||
2026-03-02 | LUNG | Pulmonx Corp | French Glendon E. III | Pres, CEO | S - Sale | $1.43 | -67,813 | 2,152,509 | -3% | -$96,973 | ||||||
2026-03-02 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $1.43 | -7,732 | 465,734 | -2% | -$11,057 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |